L. Michael Glodé, M.D.

L. Michael Glodé, M.D.

Education: Washington University SOM, St. Louis, MO – 1972


University of Colorado Denver
School of Medicine
Division of Medical Oncology
Tel: (303) 724-3853
Fax: (303) 724-3889
e-mail: mike.glode@ucdenver.edu



Dr. Glodé was the first board-certified Medical Oncologist at the University of Colorado, joining the faculty after training at Dana-Farber Cancer Institute


Dr. Glodé's research has been clinically focused on prostate cancer for many years. He headed the initial research on leuprolide, leading to it’s approval and subsequently developed a “single shot” castration agent that is in animal trials. He has also led efforts to evaluate a natural product, silibinin as a preventive or therapeutic agent and has been an investigator on more than 30 clinical trials, including the PI position for the largest adjuvant trial in prostate cancer, SWOG 9921. He has received numerous teaching awards and founded the AACR course “Molecular Biology for Clinical Oncologists” as well as serving as Founding Editor of the ASCO web site, www.asco.org.


PUBLICATIONS:   Journal Articles in Pub Med (www.pubmed.gov)